Back

Trethera Board Director Timothy Donahue appointed Weill Cornell surgery chair and surgeon-in-chief

Verifying
  • Trethera Board Director Timothy Donahue accepted two senior surgical leadership roles in New York City.
  • Donahue has authored more than 150 publications and led more than 20 research grants.
  • TRE-515 holds FDA Fast Track and Orphan Drug designations for specified diseases.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.